glp-1 ulcerative colitis Frontiers Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
This surge coincided with Zepbounds approval for OSA, marking the largest observed difference in uptake between patients with and without a comorbidity
Read more about how to use data to build a successful strategy for your employees:
Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62
Potent gastric emptying delay is common with these medications, serving as a major contributor to the ...
